This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mitchell, K. D Articles by Mullins, J. J Search for Related Content PubMed PubMed Citation Articles by Mitchell, K. D Articles by Mullins, J. J Pubmed/NCBI databases Gene GEO Profiles UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Social Bookmarking                         What's this?

Genetic Clamping of Renin Gene Expression Induces Hypertension and Elevation of Intrarenal Ang II Levels of Graded Severity in Cyp1a1-Ren2 Transgenic Rats

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana, kdmitch{at}tulane.edu

Stuart J Bagatell

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana

Chad S Miller

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana

Cynthia R Mouton

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana

Dale M Seth

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana

John J Mullins

Centre for Cardiovascular Science, University of Edinburgh Medical School, Edinburgh, Scotland, UK

Introduction. Transgenic rats with inducible angiotensin II (Ang II)-dependent hypertension (strain name: TGR[Cyp1a1-Ren2]) were generated by inserting the mouse Ren2 renin gene, fused to the cytochrome P450 1a1 (Cyp1a1) promoter, into the genome of the rat. The present study was performed to characterise the changes in plasma and kidney tissue Ang II levels and in renal haemodynamic function in Cyp1a1-Ren2 rats following induction of either slowly developing or malignant hypertension in these transgenic rats.

Materials and Methods. Arterial blood pressure (BP) and renal haemodynamics and excretory function were measured in pentobarbital sodium-anaesthetised Cyp1a1Ren2 rats fed a normal diet containing either a low dose (0.15%, w/w for 14—15 days) or high dose (0.3%, w/w for 11—12 days) of the aryl hydrocarbon indole-3-carbinol (I3C) to induce slowly developing and malignant hypertension, respectively. In parallel experiments, arterial blood samples and kidneys were harvested for measurement of Ang II levels by radioimmunoassay.

Results. Dietary I3C increased plasma renin activity (PRA), plasma Ang II levels, and arterial BP in a dose-dependent manner. Induction of different fixed levels of renin gene expression and PRA produced hypertensive phenotypes of varying severity with rats developing either mild or malignant forms of hypertensive disease. Administration of I3C, at a dose of 0.15% (w/w), induced a slowly developing form of hypertension whereas administration of a higher dose (0.3%) induced a more rapidly developing hypertension and the clinical manifestations of malignant hypertension including severe weight loss. Both hypertensive phenotypes were characterised by reduced renal plasma flow, increased filtration fraction, elevated PRA, and increased plasma and intrarenal Ang II levels. These I3C-induced changes in renal haemodynamics, PRA and kidney Ang II levels were more pronounced in Cyp1a1-Ren2 rats with malignant hypertension. Chronic administration of the AT₁-receptor antagonist, candesartan, prevented the development of hypertension, the associated changes in renal haemodynamics, and the augmentation of intrarenal Ang II levels.

Conclusions. Activation of AT₁-receptors by Ang II generated as a consequence of induction of the Cyp1a1-Ren2 transgene mediates the increased arterial pressure and the associated reduction of renal haemodynamics and enhancement of intrarenal Ang II levels in hypertensive Cyp1a1-Ren2 B transgenic rats.

Key Words: Angiotensin II • Kidney • Renal haemodynamics • Arterial blood pressure • Renin-Angiotensin system • Radioimmunoassay • Peptide hormones

References

• Byrom FB The nature of malignancy in hypertensive disease. Evidence from the retina of the rat. Lancet 1963; 1:516-20.[Web of Science][Medline] [Order article via Infotrieve]
• Gavras H., Brunner HR, Laragh JH et al. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res 1975;36(2):300-09.[Abstract/Free Full Text]
• Ploth DW Angiotensin-dependent renal mechanisms in two-kidney one-clip renal vascular hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 1983;245: F131-F141.[Abstract/Free Full Text]
• Mullins JJ, Ganten D. Transgenic animals: new approaches to hypertension research. J Hypertens 1990;8(7):35S-37S.
• Mullins JJ, Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990;344:541-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bohlender J., Fukamizu A., Lippoldt A. et al. High human renin hypertension in transgenic rats. Hypertension 1997;29:428-34.[Abstract/Free Full Text]
• Luft FC, Mervaala E., Muller DN et al. Hypertensioninduced end-organ damage: A new transgenic approach to an old problem Hypertension 1999;33:212-18.[Abstract/Free Full Text]
• Lavoie JL, Lake-Bruse KD, Sigmund CD Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 2004;286:F965-F971.[Abstract/Free Full Text]
• Kantachuvesiri S., Fleming S., Peters J. et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 2001;276:36727-33.[Abstract/Free Full Text]
• Campbell SJ, Carlotti F., Hall PA, Clark AJ, Wolf CR Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci 1996;109:2619-25.[Abstract]
• Forrester LM, Henderson CJ, Glancey MJ et al. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 1992;281:359-68.[Web of Science][Medline] [Order article via Infotrieve]
• Smith JD, Wong E., Ginsberg M. Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice. Proc Natl Acad Sci USA 1995;92:1926-30.[Abstract/Free Full Text]
• Gelboin HV Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 1980; 60:1107-66.[Free Full Text]
• Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 1993;45:1129-36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Loub WD, Wattenberg LW, Davis DW Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J Natl Cancer Inst 1975; 54:985-8.[Web of Science][Medline] [Order article via Infotrieve]
• Pelkonen O., Nebert DW Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 1982;34:189-222.[Web of Science][Medline] [Order article via Infotrieve]
• Fujii-Kuriyama Y., Masatsuga E., Junsei M., Matsushita N., Sogawa K. Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene. Pharmacogenetics 1995; 5:149-53.[CrossRef]
• Von Thun AM, Vari RC, El-Dahr SS, Navar LG Augmentation of intrarenal Angiotensin II levels by chronic Angiotensin II infusion. Am J Physiol Renal Fluid Electrolyte Physiol 1994;266:F120-F128.[Abstract/Free Full Text]
• Zou L., Hymel A., Imig JD, Navar LG Renal accumulation of circulating Angiotensin II in Angiotensin II-infused rats. Hypertension 1996;27:658-62.[Abstract/Free Full Text]
• Zou L., Imig JD, Von Thun AM, Hymel A., Ono H., Navar LG Receptor-mediated intrarenal Ang II augmentation in Ang II-infused hypertensive rats. Hypertension 1996;28:669-77.[Abstract/Free Full Text]
• Zou L., Imig JD, Hymel A., Navar LG Renal uptake of circulating Angiotensin II in Val5-Angiotensin II infused rats is mediated by AT1 E receptor. Am J Hypertens 1998;11:570-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Howard LL, Patterson ME, Mullins JJ, Mitchell KD Saltsensitive hypertension develops after transient induction of Ang II-dependent hypertension in Cyp1a1-Ren2 transgenic rats. Am J Physiol Renal Physiol 2005;288:F810-F815.[Abstract/Free Full Text]
• Patterson ME, Mouton CR, Mullins JJ, Mitchell KD Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol 2005;289:F754-F759.[Abstract/Free Full Text]
• Guan S., Fox J., Mitchell KD, Navar LG: Angiotensin and Angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension 1992;20:763-7.[Abstract/Free Full Text]
• Mitchell KD, Mullins JJ Ang II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am J Physiol Renal Fluid Electrolyte Physiol 1995;268:F821-F828.[Abstract/Free Full Text]
• Mitchell KD, Jacinto SM, Mullins JJ Proximal tubular fluid, kidney, and plasma levels of Angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol Renal Physiol 1997;273: F246-F253.[Abstract/Free Full Text]
• Fox J., Guan S., Hymel AA, Navar LG Dietary Na and ACE inhibition effects on renal tissue Angiotensin I and II and ACE activity in rats. Am J Physiol Renal Physiol 1992; 262:F902-F909.[Abstract/Free Full Text]
• Braam B., Mitchell KD, Fox J., Navar LG Proximal tubular secretion of Angiotensin II in rats. Am J Physiol Renal Physiol 1993;264:F891-F898.[Abstract/Free Full Text]
• Navar LG, Lewis L., Hymel A., Braam B., Mitchell KD Tubular fluid concentrations and kidney contents of Angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994;5:1153-8.[Abstract]
• Imig JD, Navar LG Measurement of renal tubular Angiotensin II. In: WAng D (ed.): Methods in Molecular Medicine, vol. 51: Angiotensin Protocols. Totowa, NJ: Humana Press Inc.; 2000,pp. 427-34.
• Whitworth CE, Fleming S., Cumming AD, Morton JJ et al. Spontaneous development of malignant phase hypertension in transgenic ren-2 rats. Kidney Int 1994;46:1528-32.[Web of Science][Medline] [Order article via Infotrieve]
• Mann SJ, Atlas SA Hypertensive Emergencies. In: Laragh JH, Brenner BM (eds.): Hypertension: Pathophysiology, Diagnosis, and Maintenance. 2nd ed. New York, NY: Raven; 1995, pp. 3009-22.
• Whitworth CE, Fleming S., Kotelevtsev Y. et al. A genetic model of malignant phase hypertension in rats. Kidney Int 1995;47:529-35.[Web of Science][Medline] [Order article via Infotrieve]
• Kantachuvesiri S., Haley CS, Fleming S. et al. Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. Kidney Int 1999;56:414-20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mitchell KD, Mullins JJ Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol 2005;289:F1210-F1216.[Abstract/Free Full Text]
• Blantz RC, Konnen KS, Tucker BJ Angiotensin II effects upon the glomerular ultrafiltration coefficient of the rat. J Clin Invest 1976;57:419-34.[Web of Science][Medline] [Order article via Infotrieve]
• Baylis C., Brenner BM Modulation by prostaglandin synthesis inhibitors of the action of exogenous Angiotensin II on glomerular ultrafiltration in the rat. Circ Res 1978; 43:889-98.[Abstract/Free Full Text]
• Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-36.[Abstract/Free Full Text]
• Mitchell KD, Navar LG Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Laragh JH, Brenner BM (eds.): Hypertension: Pathophysiology, Diagnosis, and Maintenance. 2nd ed. New York, NY: Raven; 1995, pp.1437-50.
• Kobori H., Prieto-Carrasquero C., Ozawa Y., Navar LG AT1 receptor mediated augmentation of intrarenal angiotensinogen in Angiotensin II-dependent hypertension. Hypertension 2004;43:1126-32.[Abstract/Free Full Text]
• Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, El-Dahr SS Immunohistochemical localization of Ang II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol Renal Physiol 1997;273:F170-F177.[Abstract/Free Full Text]
• Graciano ML, Mouton C., Patterson ME, Mullins JJ, Mitchell KD Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with malignant hypertension. FASEB J 2005;19:A548.

Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 2, 74-86 (2006)
DOI: 10.3317/jraas.2006.013


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Peters, T. Schluter, T. Riegel, B. S. Peters, A. Beineke, U. Maschke, N. Hosten, J. J. Mullins, and R. Rettig Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1845 - H1852. [Abstract] [Full Text] [PDF]

				X. Liu, C. O. C. Bellamy, M. A. Bailey, L. J. Mullins, D. R. Dunbar, C. J. Kenyon, G. Brooker, S. Kantachuvesiri, K. Maratou, A. Ashek, et al. Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage J. Biol. Chem., June 5, 2009; 284(23): 15564 - 15572. [Abstract] [Full Text] [PDF]

				W. Shao, D. M. Seth, and L. G. Navar Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1067 - F1071. [Abstract] [Full Text] [PDF]

				R. M. Ortiz Delineating the contributions of AT1a and AT1b receptor-mediated uptake of ANG II in kidneys and adrenals Am J Physiol Renal Physiol, February 1, 2008; 294(2): F291 - F292. [Full Text] [PDF]

				M. E. Patterson, J. J. Mullins, and K. D. Mitchell Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension Am J Physiol Renal Physiol, January 1, 2008; 294(1): F205 - F211. [Abstract] [Full Text] [PDF]

				R. M. Ortiz, M. L. Graciano, J. J. Mullins, and K. D. Mitchell Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1584 - F1591. [Abstract] [Full Text] [PDF]

				M. L. Graciano, C. R. Mouton, M. E. Patterson, D. M. Seth, J. J. Mullins, and K. D. Mitchell Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1858 - F1866. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mitchell, K. D Articles by Mullins, J. J Search for Related Content PubMed PubMed Citation Articles by Mitchell, K. D Articles by Mullins, J. J Pubmed/NCBI databases Gene GEO Profiles UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Social Bookmarking                         What's this?